QYUNS-B repurchases 25,200 H shares for HKD 0.39 million, treasury stock rises to 3.07 million

Bulletin Express06-04

Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share buyback in a Next Day Disclosure Return filed on 4 June 2026.

The company repurchased 25,200 H shares on the Hong Kong Stock Exchange on 4 June 2026 at prices ranging from HKD 15.31 to HKD 15.80, with a volume-weighted average price of HKD 15.55. The total consideration was approximately HKD 0.39 million.

Following the transaction, the number of issued shares (excluding treasury shares) fell by 0.0112 % to 224.00 million, while treasury shares increased to 3.07 million. Total issued shares remained unchanged at 227.07 million.

The buyback was executed under the repurchase mandate approved on 29 May 2026, which authorises the company to repurchase up to 22.44 million shares. Cumulative repurchases under this mandate now stand at 363,400 shares, equivalent to 0.162 % of the issued share capital on the mandate date.

In accordance with listing rules, QYUNS-B is subject to a moratorium on new share issues or treasury share disposals until 4 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180908088?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 20:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180908088","market":"hk","top_or_hot":-1,"title":"QYUNS-B repurchases 25,200 H shares for HKD 0.39 million, treasury stock rises to 3.07 million","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share buyback in a Next Day Disclosure Return filed on 4 June 2026.</p>\n<p>The company repurchased 25,200 H shares on the Hong Kong Stock Exchange on 4 June 2026 at prices ranging from HKD 15.31 to HKD 15.80, with a volume-weighted average price of HKD 15.55. The total consideration was approximately HKD 0.39 million.</p>\n<p>Following the transaction, the number of issued shares (excluding treasury shares) fell by 0.0112 % to 224.00 million, while treasury shares increased to 3.07 million. Total issued shares remained unchanged at 227.07 million.</p>\n<p>The buyback was executed under the repurchase mandate approved on 29 May 2026, which authorises the company to repurchase up to 22.44 million shares. Cumulative repurchases under this mandate now stand at 363,400 shares, equivalent to 0.162 % of the issued share capital on the mandate date.</p>\n<p>In accordance with listing rules, QYUNS-B is subject to a moratorium on new share issues or treasury share disposals until 4 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>QYUNS-B repurchases 25,200 H shares for HKD 0.39 million, treasury stock rises to 3.07 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQYUNS-B repurchases 25,200 H shares for HKD 0.39 million, treasury stock rises to 3.07 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 20:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share buyback in a Next Day Disclosure Return filed on 4 June 2026.</p>\n<p>The company repurchased 25,200 H shares on the Hong Kong Stock Exchange on 4 June 2026 at prices ranging from HKD 15.31 to HKD 15.80, with a volume-weighted average price of HKD 15.55. The total consideration was approximately HKD 0.39 million.</p>\n<p>Following the transaction, the number of issued shares (excluding treasury shares) fell by 0.0112 % to 224.00 million, while treasury shares increased to 3.07 million. Total issued shares remained unchanged at 227.07 million.</p>\n<p>The buyback was executed under the repurchase mandate approved on 29 May 2026, which authorises the company to repurchase up to 22.44 million shares. Cumulative repurchases under this mandate now stand at 363,400 shares, equivalent to 0.162 % of the issued share capital on the mandate date.</p>\n<p>In accordance with listing rules, QYUNS-B is subject to a moratorium on new share issues or treasury share disposals until 4 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1180908088","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180908088","pubTimestamp":1780575764,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share buyback in a Next Day Disclosure Return filed on 4 June 2026. The company repurchased 25,200 H shares on the Hong Kong Stock Exchange on 4...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"QYUNS-B以39万港元回购2.52万股H股库存股升至307万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share buyback in a Next Day Disclosure Return filed on 4 June 2026.\nThe company repurchased 25,200 H shares on the Hong Kong Stock Exchange on 4 June 2026 at prices ranging from HKD 15.31 to HKD 15.80, with a volume-weighted average price of HKD 15.55. The total consideration was approximately HKD 0.39 million.\nFollowing the transaction, the number of issued shares (excluding treasury shares) fell by 0.0112 % to 224.00 million, while treasury shares increased to 3.07 million. Total issued shares remained unchanged at 227.07 million.\nThe buyback was executed under the repurchase mandate approved on 29 May 2026, which authorises the company to repurchase up to 22.44 million shares. Cumulative repurchases under this mandate now stand at 363,400 shares, equivalent to 0.162 % of the issued share capital on the mandate date.\nIn accordance with listing rules, QYUNS-B is subject to a moratorium on new share issues or treasury share disposals until 4 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180908088","isCrawlerRequest":true}